Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc. demonstrates a strong financial outlook, highlighted by a projected client count increase in 4Q25 and an expected adjusted operating income margin of approximately 22.4%, representing a substantial year-over-year improvement. The company exhibited impressive revenue growth of 53.3% and significant operating margin expansion, emphasizing effective marketing strategies and an innovative platform that enhances member engagement while driving yield improvements. With a current penetration rate of around 3.5%, significantly below traditional physical therapy rates, Hinge Health possesses considerable growth potential by leveraging tools like Hinge Connect to optimize client outreach and increase overall yields.

Bears say

Hinge Health Inc. faces a concerning trend in its financial metrics, as adjusted R&D expenditures are projected to decrease significantly from 23.7% of revenue in 3Q24 to 14.5% in 3Q25, indicating potential challenges in innovation and development. Furthermore, management's guidance expects mid-teens EBIT margins in the second half of 2025, which reflects a decline from the 19% margin reported in 2Q25 and suggests that FY26/FY27 consensus margins of 14.6% and 16.2% may be unsustainably low. Lastly, the anticipated decline in membership during the holiday season, coupled with reduced spending in sales and marketing, raises concerns about the company's ability to maintain revenue growth and profitability moving forward.

HNGE has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 15 analysts, HNGE has a Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $60.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $60.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.